23
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Impact of Nanoparticles on Brain Health: An Up to Date Overview

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nanoparticles are zero-dimensional nanomaterials and, based on their nature, they can be categorized into organic, inorganic, and composites nanoparticles. Due to their unique physical and chemical properties, nanoparticles are extensively used in a variety of fields, including medicine, pharmaceutics, and food industry. Although they have the potential to improve the diagnosis and treatment of brain diseases, it is fundamentally important to develop standardized toxicological studies, which can prevent the induction of neurotoxic effects. The focus of this review is to emphasize both the beneficial and negative effects of nanoparticles on brain health.

          Related collections

          Most cited references92

          • Record: found
          • Abstract: not found
          • Article: not found
          Is Open Access

          Nanoparticles: Properties, applications and toxicities

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found
            Is Open Access

            Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.

            The blood-brain barrier (BBB) is a vital boundary between neural tissue and circulating blood. The BBB's unique and protective features control brain homeostasis as well as ion and molecule movement. Failure in maintaining any of these components results in the breakdown of this specialized multicellular structure and consequently promotes neuroinflammation and neurodegeneration. In several high incidence pathologies such as stroke, Alzheimer's (AD) and Parkinson's disease (PD) the BBB is impaired. However, even a damaged and more permeable BBB can pose serious challenges to drug delivery into the brain. The use of nanoparticle (NP) formulations able to encapsulate molecules with therapeutic value, while targeting specific transport processes in the brain vasculature, may enhance drug transport through the BBB in neurodegenerative/ischemic disorders and target relevant regions in the brain for regenerative processes. In this review, we will discuss BBB composition and characteristics and how these features are altered in pathology, namely in stroke, AD and PD. Additionally, factors influencing an efficient intravenous delivery of polymeric and inorganic NPs into the brain as well as NP-related delivery systems with the most promising functional outcomes will also be discussed.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Recent biomedical applications of gold nanoparticles: A review

                Bookmark

                Author and article information

                Journal
                J Clin Med
                J Clin Med
                jcm
                Journal of Clinical Medicine
                MDPI
                2077-0383
                27 November 2018
                December 2018
                : 7
                : 12
                : 490
                Affiliations
                [1 ]Emergency University Hospital, Bucharest, Romania, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania; telepapa@ 123456hotmail.com (D.M.T.); raluca.teleanu@ 123456umfcd.ro (R.I.T.)
                [2 ]Faculty of Engineering in Foreign Languages, 060042 Bucharest, Romania; cristina.chircov@ 123456yahoo.com
                [3 ]Department of Science and Engineering of Oxide Materials and Nanomaterials, Faculty of Applied Chemistry and Materials Science, Politehnica University of Bucharest, 011061 Bucharest, Romania; grumezescu@ 123456yahoo.com
                [4 ]ICUB—Research Institute of University of Bucharest, University of Bucharest, 36-46 M. Kogalniceanu Blvd., 050107 Bucharest, Romania
                Author notes
                [* ]Correspondence: avolceanov@ 123456yahoo.co.uk ; Tel.: +4021–402-3997
                Author information
                https://orcid.org/0000-0002-7668-861X
                Article
                jcm-07-00490
                10.3390/jcm7120490
                6306759
                30486404
                e29c623d-6014-4baf-9e72-99e3c4abe054
                © 2018 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 24 October 2018
                : 23 November 2018
                Categories
                Review

                nanoparticles,zero-dimensional,organic nanoparticles,inorganic nanoparticles,diagnosis,treatment,brain diseases,brain tumors,neurodegenerative disorders,brain health

                Comments

                Comment on this article